| PUBCHEM ID |
76967404
|
| UNII |
9ABD9DRK7B
|
| Preferred Term |
1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM
|
| CAS |
|
| INCHIKEY |
WQHSICGELLFGCC-JCYCRQSBSA-L
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC(O[C@@H](COC(CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)CO[P@@](O)(OC[C@H](C(O)=O)N)=O)=O
|
| Total Surface Area |
741,46
|
| Relative PSA |
0,18559
|
| TPSA |
181,49
|
| cLogS |
-7,068
|
| MW |
842,06
|
| cLogP |
8,4503
|
| H-Acceptors |
11
|
| H-Donors |
3
|
| Ro5 violations |
3
|
| Druglikeness |
-58,066
|
| DrugScore |
0,07281639666814
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,7355
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,8557
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
-0,0659
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,3592
|
| Carcinogenicity (Three-class) |
Non-required
|
